Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Opioid-Induced Sedation in Cancer
NCT00352664Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2003
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil, sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2003; status: terminated.
02
Drugs
donepezil
Beyond the preview
Go deeper on NCT00352664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352664.